Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/26/2010EP1497278B1 Heterocyclic amide derivatives as cytokine inhibitors
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010EP1438321B1 Modified l-nucleic acid
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010EP1370275B1 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
05/26/2010EP1315709B1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
05/26/2010EP1303495B1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
05/26/2010EP1294371B2 Medium chain fatty acids applicable as antimicrobial agents
05/26/2010EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
05/26/2010EP1144642B1 Compounds and methods for treatment and diagnosis of chlamydial infection
05/26/2010EP1132383B1 Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
05/26/2010CN201481641U Eyesight improving goggles
05/26/2010CN1993361B Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/26/2010CN1984656B Cancer treatment method
05/26/2010CN1980650B Vaginal health products
05/26/2010CN1974545B Long chain fatty acyl amide compound and its application
05/26/2010CN1972931B Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia
05/26/2010CN1969903B Acanthopanax extract for preventing and treating cardiovascular and cerebrovascular disease and preparation process thereof
05/26/2010CN1969814B Nasal administered preparation of melatonin
05/26/2010CN1960736B Anti-infectious hydrogel compositions
05/26/2010CN1956983B 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
05/26/2010CN1956961B Stable crystal form of 4-oxoquinoline compound
05/26/2010CN1953983B 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
05/26/2010CN1951483B Hybrid safflower oil and preparation method thereof
05/26/2010CN1943565B Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method
05/26/2010CN1942194B Use of Spinosad in preparing medicine for wound healing
05/26/2010CN1942182B Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism
05/26/2010CN1935277B Preparation for the prophylaxis of restenosis
05/26/2010CN1935187B Injectionagent for treating mammary gland proliferation
05/26/2010CN1934120B Novel inhibitors of chymase
05/26/2010CN1922183B Nitrogenous fused heteroaromatic ring derivative
05/26/2010CN1916050B Injectable temperature sensitive hydrogel of poly (lactide - glycolide - p-dioxane ketone) - polyethyleneglycol block copolymer
05/26/2010CN1915991B Synthesis of indole thiazole compounds as ligands for the ah receptor
05/26/2010CN1913878B Transdermal delivery of hormones without the need of penetration enhancers
05/26/2010CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen
05/26/2010CN1910185B Pyrrolopyrimidine and pyrrolotriazine derivatives as CRF receptor antagon
05/26/2010CN1910153B Derivatives of pyridine and quinoline
05/26/2010CN1909894B Pharmaceutical composition
05/26/2010CN1899401B Three ingredient body comfort liquid
05/26/2010CN1897935B Use of rotigotine for treatment or prevention of dopaminergic neurone loss
05/26/2010CN1895546B Lycium chinensis polyose medicinal composition with therapeutic and health-care functions
05/26/2010CN1895353B Preparation of compound Danshen tablets
05/26/2010CN1893934B Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases
05/26/2010CN1893932B Microemulsion preconcentrate comprising a renin inhibitor
05/26/2010CN1879615B Anti-tumor synergistic pharmaceutical composition
05/26/2010CN1875022B Tocopherol-modified therapeutic drug compounds
05/26/2010CN1871010B Prophylaxis and/or treatment of portal hypertension
05/26/2010CN1870982B Composition containing reduced coenzyme q
05/26/2010CN1870910B Synbiotic composition for infants
05/26/2010CN1867331B Thalidomide analogs as TNF-alpha modulators
05/26/2010CN1859948B Carbostyril derivatives for accelerating salivation
05/26/2010CN1856478B Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
05/26/2010CN1849117B Entry inhibitors of the HIV virus
05/26/2010CN1842337B Stable 5,10-methylene-tetrahydrofolate pharmaceutical compounds
05/26/2010CN1835948B 2-acylaminothiazole derivative or its salt
05/26/2010CN1827107B Substained analgesia achieved with buprenorphine
05/26/2010CN1826115B Substituted piperidine compounds and methods of their use
05/26/2010CN1823083B Lincomycin derivatives possessing antibacterial activity
05/26/2010CN1822848B Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions
05/26/2010CN1820011B Use of rapamycin and rapamycin derivatives for the treatment of bone loss
05/26/2010CN1816626B Antisense oligonucleotide having anticancerous activity
05/26/2010CN1809531B Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
05/26/2010CN1805748B 2-aminopyrimidine derivatives as RAF kinase inhibitors
05/26/2010CN1803189B Use of neurotoxin therapy for treatment of urologic and related disorders
05/26/2010CN1803144B Pharmaceutical composition containing clofibrate compound and B family vitamin
05/26/2010CN1799559B Chinese medicinal gel formulation, its preparation process and quality control method
05/26/2010CN1795926B Pharamaceutical use for treating skin conditions
05/26/2010CN1794999B Remedy for nerve damage
05/26/2010CN1794976B Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals
05/26/2010CN1781545B Method for extracting herbal medicine
05/26/2010CN1780826B Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
05/26/2010CN1767838B Biocompatible dialysis fluids containing icodextrins
05/26/2010CN1764468B Skin protecting composition
05/26/2010CN1761669B Preparation of a trans-calanolide ketone intermediate
05/26/2010CN1758920B Cystitis treatment with high dose chondroitin sulfate
05/26/2010CN1753683B Ophthalmic formulation for the prevention and treatment of ocular conditions
05/26/2010CN1750809B Fast dissolving orally consumable films containing pharmaceutically active agents
05/26/2010CN1744902B Pharmaceutical combination for the treatment of cancer
05/26/2010CN1741799B Combination of antidiabetic drugs
05/26/2010CN1739549B Preparation process of active medicinal lignin matter and its use in treating cardiac vascular diseases
05/26/2010CN1736384B Mixture of higher primary aliphatic alcohols with acetylsalicylic acid and pharmaceutical formulation
05/26/2010CN1731995B Device for the transdermal administration of a rotigotine base
05/26/2010CN1726217B Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
05/26/2010CN1723206B High specificity anticancer pharmacological drug system, drug synthesis, and drug development process
05/26/2010CN1713907B N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors
05/26/2010CN1711279B Epstein Barr virus peptide epitopes, polyepitopes and delivery system therefor
05/26/2010CN1703202B Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier
05/26/2010CN1699401B Novel anti-cancer active compound and its extraction process
05/26/2010CN1692914B Application of timosaponin B II for preparing medicine or products for treating and preventing stroke
05/26/2010CN1690057B Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
05/26/2010CN1684709B Medicine carrier for local application
05/26/2010CN1684668B Sustained release delivery of amphetamine salts
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1681386B Compositions and products containing s-equol, and methods for their making
05/26/2010CN1671407B Compositions and methods for treating diabetes
05/26/2010CN1671380B Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
05/26/2010CN1665933B Immunoconjugates for the treatment of tumours
05/26/2010CN1665507B Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
05/26/2010CN1662642B Pasteurisation process for microbial cells and microbial oil
05/26/2010CN1662229B Use of taurine or hypotaurine for preparing medicine for the treatment of alopecia
1 ... 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 ... 7860